Pharmaceuticals - Community Register

  

List of nationally authorised medicinal products for human use

Paroxetine

Product name: Paroxetine
Also marketed in the EU under the name(s): Allenopar, Apo-Parox, Apodepi, Arketis, Aropax, Aroxetin, Calmus, Casbol, Daparox, Denerval, Deoxatine, Depar, Deprozel, Deroxat, Divarius, Ennos, Eoxat, Euplix, Eutimil, Frosinor, Genpar, Glaxopar, Isoxatine, Mediparox, Medoxatine, Meloxat, Meparox, Meradel, Motivan, Optipar, Osepar, Oxepar, Oxet, Oxetine, Paluxetil, Paraxodil, Paretin, Parhun, Paroc, Parocetan, Parogen, Paroglax, Parolex, ParoLich, Paroneurin, Paroscope, Parotamed, Parox, Paroxat, Paroxedura, Paroxegen, Paroxetabs, Paroxetin , Paroxetina, Paroxetinhexal, Paroxetini, Paroxetiphar, Paroxiflex, Paroximed, Paroxistad, Parsyn, Pasero, Pasorex, Paxeratio, Paxetil, Paxetin, Paxil, Paxpar, Paxtin, Primoxatine, Remood, Rexetin, Rextine, Roxac, Sereupin, Serodur, Serorex, Seroxat, Seroxetabs, Sopax, Tagonis, Titroxatine, Trapar, Varoxetin, Xetin, Zwapar
Active substance: Paroxetine
Indication: ­Major Depressive Episode
­Obsessive Compulsive Disorder
­Panic Disorder with and without agoraphobia
­Social Anxiety Disorders/Social phobia
­Generalised Anxiety Disorder
­Post-traumatic Stress Disorder
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/03/2005 Referral EMEA/H/A-31/558 (2005)1067 of 29/03/2005